mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.007 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.007 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.007 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.008 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |